Ginkgo Bioworks Holdings, Inc. (DNA) Stock Grade

About Ginkgo Bioworks Holdings, Inc.'s fundamentals

Ginkgo Bioworks is a biotechnology company with a market capitalization of $683.3 million that reported a net loss in its latest annual statement, reflected in a negative net margin of -183.8%. The company experienced a significant year-over-year revenue decline of 25.1%, indicating shrinking top-line performance. The company does not pay a dividend and lacks positive profitability metrics, as evidenced by the inability to calculate meaningful P/E and return on equity figures based on earnings.